June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Stable classification of diabetic structures from incorrectly labeled OCTA enface images using multiple instance learning
Author Affiliations & Notes
  • Philipp Matten
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
  • Julius Scherer
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
  • Thomas Schlegl
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
  • Jonas Nienhaus
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
  • Heiko Stino
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
  • Andreas Pollreisz
    Department of Ophthalmology, Medical University of Vienna, Vienna, Vienna, Austria
  • Wolfgang Drexler
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
  • Rainer A Leitgeb
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
  • Tilman Schmoll
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Vienna, Austria
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Footnotes
    Commercial Relationships   Philipp Matten Carl Zeiss Meditec AG, Code C (Consultant/Contractor); Julius Scherer Carl Zeiss Meditec AG, Code C (Consultant/Contractor); Thomas Schlegl Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor); Jonas Nienhaus Carl Zeiss Meditec AG, Code C (Consultant/Contractor); Heiko Stino None; Andreas Pollreisz Bayer, Roche, Novartis, and Oertli Instruments, Code C (Consultant/Contractor), Roche, and Carl Zeiss Meditec, Inc., Code F (Financial Support); Wolfgang Drexler Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Inc., Code F (Financial Support); Rainer Leitgeb Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Inc., Code F (Financial Support); Tilman Schmoll Carl Zeiss Meditec Inc., Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1087. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Philipp Matten, Julius Scherer, Thomas Schlegl, Jonas Nienhaus, Heiko Stino, Andreas Pollreisz, Wolfgang Drexler, Rainer A Leitgeb, Tilman Schmoll; Stable classification of diabetic structures from incorrectly labeled OCTA enface images using multiple instance learning. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1087.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Early diagnosis and monitoring of the progression of diabetic retinopathy (DR) are crucial to help prevent permanent loss of vision in patients. Artificial intelligence (AI)-algorithms have been utilized to classify DR and even its severity. However, most algorithms are based on supervised learning which requires precise labels for the training data. We minimize this necessity via a multiple instance learning (MIL) machine learning approach.

Methods : MIL only uses a set of instances, so-called bags, in which all instances inherit one global bag label - in our case diabetic or not. The algorithm then learns to classify these instances, based on the inherited bag label. 352 OCTA enface images from 102 patients (d) and 40 healthy (h) volunteers were collected and split - 211/64 (d/h) for training, 24/24 for validation 22/8 for testing. Bags are preprocessed and then run through the classifier (Figure 1). MIL-ResNet14 was evaluated against two other network architectures that have been proven capable: ResNet14, and VGG16.

Results : Our proposed network, MIL-ResNet14, provided an F1-score (harmonic mean of precision and recall) of 0.950, VGG16 of 0.857, and ResNet14 of 0.909. MIL-ResNet14 outperformed both ResNet14 and VGG16 in detecting vasculature changes of diabetes, such as ischemic areas and abnormal vessel branches, which we validate visually with Grad-CAM overlays (Figure 2). MIL-ResNet14 also accurately classified cases in-between healthy and very diabetic more accurately than both other networks.

Conclusions : Minimizing the necessity of expert grader labelling makes AI-based classification algorithms much easier in terms of data preparation. From our comparison with established classifiers, we conclude that MIL has a regularizing effect on incorrectly labeled data sets and is therefore a clinically more reliable classification architecture than previously proposed methods.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Figure 1: Architecture of the proposed network, MIL-ResNet14. Images are pre-processed and then sub-divided into instances, each inheriting the global image label for training and validation (a) and are then passed into the instance classifier and MIL pooling parts (b).

Figure 1: Architecture of the proposed network, MIL-ResNet14. Images are pre-processed and then sub-divided into instances, each inheriting the global image label for training and validation (a) and are then passed into the instance classifier and MIL pooling parts (b).

 

Figure 2: Grad-CAM overlays of all three networks onto OCTA enface example image of a diabetic patient; (a) ResNet14; (b): VGG16; (c): ResNet14. Blue arrows indicate ischemic areas and pink arrows point to vascular abnormalities.

Figure 2: Grad-CAM overlays of all three networks onto OCTA enface example image of a diabetic patient; (a) ResNet14; (b): VGG16; (c): ResNet14. Blue arrows indicate ischemic areas and pink arrows point to vascular abnormalities.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×